[Forty years of progress in the therapeutic management of lung cancer]

P Van Houtte; M Roelandts; F Mornex

doi:10.1016/j.canrad.2014.07.144

[Forty years of progress in the therapeutic management of lung cancer]

Cancer Radiother. 2014 Oct;18(5-6):396-401. doi: 10.1016/j.canrad.2014.07.144. Epub 2014 Sep 4.

[Article in French]

Authors

P Van Houtte¹, M Roelandts², F Mornex³

Affiliations

¹ Département de radio-oncologie, institut Jules-Bordet, université Libre de Bruxelles, 121, boulevard de Waterloo, 1000 Bruxelles, Belgique. Electronic address: paul.vanhoutte@bordet.be.
² Département de radio-oncologie, institut Jules-Bordet, université Libre de Bruxelles, 121, boulevard de Waterloo, 1000 Bruxelles, Belgique.
³ Département de radiothérapie oncologie, centre hospitalier Lyon Sud, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, France; EMR 3738, université Claude-Bernard Lyon 1, 69373 Lyon cedex 08, France.

PMID: 25195118
DOI: 10.1016/j.canrad.2014.07.144

Abstract

This article reviews and describes the progress made in the therapeutic management of patients suffering from a lung cancer, outlining the major improvements made and suggesting some perspectives for the future.

Keywords: Cancer bronchique; Historique du cancer du poumon; Lung cancer; Lung cancer history; Progrès thérapeutiques; Radiotherapy; Radiothérapie; Therapeutic improvements.

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chemoradiotherapy / trends
Cisplatin / administration & dosage
Clinical Trials as Topic
Combined Modality Therapy
Disease Management
Dose Fractionation, Radiation
Humans
Lung Neoplasms / radiotherapy*
Lung Neoplasms / therapy
Meta-Analysis as Topic
Neoadjuvant Therapy / trends
Particle Accelerators
Pneumonectomy
Radiation Oncology / trends*
Radiotherapy / instrumentation
Radiotherapy / methods
Radiotherapy / trends
Radiotherapy, Image-Guided
Therapies, Investigational / trends

Substances

Cisplatin